Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Varicella-zoster virus encodes several envelope-associated glycoproteins—most notably the essential trio of gB, gH, and gL—that orchestrate attachment to host cells, trigger membrane fusion events needed for infection/spread, undergo significant post-translational modification including N-glycosylation/phosphorylation/ubiquitination during biosynthesis/trafficking through ER/Golgi pathways before incorporation into new virions. These molecules serve as key determinants of viral pathogenicity/tropism/immunogenicity.
Neutralizing antibodies target conformational epitopes on surface-exposed glycoproteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Varicella-zoster virus glycoproteins (VZV glycoproteins).